phase III clinical study
Novartis to Seek Approval for Intrathecal SMA Gene Therapy in Children, Young Adults in Early 2025
An intravenous form of the gene therapy is already approved and sold as Zolgensma in the US for patients less than 2 years of age.
FDA Approves BeiGene's Tevimbra in First-Line PD-L1-Positive Esophageal Cancers
Patients with PD-L1-positive tumors lived more than seven months longer on Tevimbra added to chemotherapy compared to just chemo.
Adverum Biotechnologies Kicks Off Registrational Trial for Wet AMD Gene Therapy
In the randomized, sham-controlled ARTEMIS study, patients will receive either a dose of ixo-vec or a standard care regimen of anti-VEGF Eylea.
AstraZeneca Taking Phase III Data on Camizestrant, CDK4/6 Combination to Regulators
Interim data has shown benefits of the camizestrant combo over standard treatment in ESR1-mutant breast cancer.
Cel-Sci to Initiate Phase III Trial of Immunotherapy in PD-L1-Low Head and Neck Cancer
The registrational trial will include 212 patients who are newly diagnosed with advanced head and neck cancer.
Jan 30, 2025
Jan 15, 2025
Jan 14, 2025